$CHCT
Community Healthcare Trust Inc Stock $chct

$chct Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000163156923000040 Filed on May 02, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$27.81M	$27.18M
YoY Change	15.64%	15.74%
Cost Of Revenue	$4.786M	$4.873M
YoY Change	17.82%	19.12%
Gross Profit	$23.02M	$22.30M
YoY Change	15.19%	15.02%
Gross Profit Margin	82.79%	82.07%
Selling, General & Admin	$3.787M	$16.20M
YoY Change	4.9%	388.69%
% of Gross Profit	16.45%	72.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.219M	$9.018M
YoY Change	14.14%	13.55%
% of Gross Profit	40.04%	40.43%
Operating Expenses	$13.01M	$30.10M
YoY Change	-17.42%	96.08%
Operating Profit	$10.02M	-$7.793M
YoY Change	136.39%	-292.85%
Interest Expense	-$4.091M	$3.992M
YoY Change	-248.49%	52.02%
% of Operating Profit	-40.84%
Other Income/Expense, Net	-$3.441M	-$4.002M
YoY Change
Pretax Income	$6.627M	-$6.887M
YoY Change	-20.16%	-184.69%
Income Tax	$50.00K	$35.00K
% Of Pretax Income	0.75%
Net Earnings	$6.027M	-$6.922M
YoY Change	7.93%	-225.31%
Net Earnings / Revenue	21.67%	-25.47%
Basic Earnings Per Share	$0.24	-$0.32
Diluted Earnings Per Share	$0.24	-$0.32
COMMON SHARES
Basic Shares Outstanding	26.30M shares	26.02M shares
Diluted Shares Outstanding	25.07M shares	24.23M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.627M	$3.666M
YoY Change	54.62%	211.21%
Cash & Equivalents	$2.627M	$3.666M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$2.627M	$3.666M
YoY Change	54.62%	211.21%
LONG-TERM ASSETS
Property, Plant & Equipment	$808.4M	$800.0M
YoY Change	12.28%	13.89%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.786M	$3.201M
YoY Change	89.47%	29.18%
Total Long-Term Assets	$897.8M	$882.6M
YoY Change	14.47%	16.13%
TOTAL ASSETS
Total Short-Term Assets	$2.627M	$3.666M
Total Long-Term Assets	$897.8M	$882.6M
Total Assets	$900.5M	$886.3M
YoY Change	14.56%	16.43%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.61M	$10.48M
YoY Change	46.9%	51.99%
Accrued Expenses	$780.0K	$783.0K
YoY Change	-1.39%	-1.26%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.05M	$14.88M
YoY Change	13.7%	20.97%
LONG-TERM LIABILITIES
Long-Term Debt	$371.4M	$368.3M
YoY Change	26.03%	35.1%
Other Long-Term Liabilities	$8.689M	$8.564M
YoY Change	69.01%	65.42%
Total Long-Term Liabilities	$380.1M	$376.9M
YoY Change	26.77%	35.66%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.05M	$14.88M
Total Long-Term Liabilities	$380.1M	$376.9M
Total Liabilities	$395.1M	$391.8M
YoY Change	26.21%	35.04%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$657.3M	$648.6M
YoY Change	9.58%	8.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$505.3M	$494.5M
YoY Change
Total Liabilities & Shareholders Equity	$900.5M	$886.3M
YoY Change	14.56%	16.43%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$6.027M	-$6.922M
YoY Change	7.93%	-225.31%
Depreciation, Depletion And Amortization	$9.219M	$9.018M
YoY Change	14.14%	13.55%
Cash From Operating Activities	$16.68M	$12.70M
YoY Change	10.31%	-11.83%
INVESTING ACTIVITIES
Capital Expenditures	$19.56M	$28.03M
YoY Change	-179.58%	-462.32%
Acquisitions
YoY Change
Other Investing Activities	$3.088M	-$545.0K
YoY Change	-511.73%	-27.33%
Cash From Investing Activities	-$16.47M	-$28.58M
YoY Change	-34.96%	236.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.150M	$8.437M
YoY Change	-110.58%	-219.12%
NET CHANGE
Cash From Operating Activities	16.68M	$12.70M
Cash From Investing Activities	-16.47M	-$28.58M
Cash From Financing Activities	-1.150M	$8.437M
Net Change In Cash	-949.0K	-$7.443M
YoY Change	-244.01%	537.24%
FREE CASH FLOW
Cash From Operating Activities	$16.68M	$12.70M
Capital Expenditures	$19.56M	$28.03M
Free Cash Flow	-$2.887M	-$15.34M
YoY Change	-107.27%	-169.27%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001631569
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssets
CY2022Q4	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherAssets
CY2023Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#InterestExpense
CY2023Q1	us-gaap	Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2022#InterestExpense
CY2022Q1	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q4	us-gaap	Finance Lease Liability Statement Of Financial Position Extensible List FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q4	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2022Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OtherLiabilities
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-37401
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	Community Healthcare Trust Inc
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-5212033
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3326 Aspen Grove Drive
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 150
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Franklin
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	TN
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	37067
CY2023Q1	dei	City Area Code CityAreaCode	615
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	771-3052
CY2023Q1	dei	Security12b Title Security12bTitle	Common stock, $0.01 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	CHCT
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	26304425	shares
CY2023Q1	us-gaap	Land And Land Improvements LandAndLandImprovements	122702000	usd
CY2022Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	117657000	usd
CY2023Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	848060000	usd
CY2022Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	825257000	usd
CY2023Q1	chct	Real Estate Personal Property RealEstatePersonalProperty	264000	usd
CY2022Q4	chct	Real Estate Personal Property RealEstatePersonalProperty	253000	usd
CY2023Q1	chct	Real Estate Investment Property At Cost Excluding Finance Lease RealEstateInvestmentPropertyAtCostExcludingFinanceLease	971026000	usd
CY2022Q4	chct	Real Estate Investment Property At Cost Excluding Finance Lease RealEstateInvestmentPropertyAtCostExcludingFinanceLease	943167000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	174346000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	165341000	usd
CY2023Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	796680000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	777826000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3666000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11233000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	959000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	835000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	84989000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	86531000	usd
CY2023Q1	us-gaap	Assets Assets	886294000	usd
CY2022Q4	us-gaap	Assets Assets	876425000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	365061000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	352997000	usd
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	10478000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	11377000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	16240000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	15237000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	391779000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	379611000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	26274000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26274000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25897000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	25897000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	263000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	259000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	648384000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	625136000	usd
CY2023Q1	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	74220000	usd
CY2022Q4	us-gaap	Cumulative Earnings Deficit CumulativeEarningsDeficit	81142000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	15684000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	22667000	usd
CY2023Q1	us-gaap	Cumulative Dividends CumulativeDividends	244036000	usd
CY2022Q4	us-gaap	Cumulative Dividends CumulativeDividends	232390000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	494515000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	496814000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	886294000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	876425000	usd
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	26128000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	22604000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1048000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	877000	usd
CY2023Q1	us-gaap	Revenues Revenues	27176000	usd
CY2022Q1	us-gaap	Revenues Revenues	23481000	usd
CY2023Q1	chct	Operating Expenses Property OperatingExpensesProperty	4873000	usd
CY2022Q1	chct	Operating Expenses Property OperatingExpensesProperty	4091000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16205000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3316000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9018000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7942000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	30096000	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	15349000	usd
CY2023Q1	chct	Income Loss From Continuing Operations Before Income Taxes Noncontrolling Interest And Other Items IncomeLossFromContinuingOperationsBeforeIncomeTaxesNoncontrollingInterestAndOtherItems	-2920000	usd
CY2022Q1	chct	Income Loss From Continuing Operations Before Income Taxes Noncontrolling Interest And Other Items IncomeLossFromContinuingOperationsBeforeIncomeTaxesNoncontrollingInterestAndOtherItems	8132000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	3992000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	2626000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	35000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-17000	usd
CY2023Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	25000	usd
CY2022Q1	us-gaap	Interest And Other Income InterestAndOtherIncome	1000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6922000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5524000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24227000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23570000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24227000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23570000	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14300000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	11800000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6922000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5524000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-4973000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	11407000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	2010000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-1115000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-6983000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	12522000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13905000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18046000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	496814000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	8906000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14346000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-4973000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	2010000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6922000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.4475
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	11646000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	494515000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	462112000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-197000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2122000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	11407000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-1115000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5524000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.4375
CY2022Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	10969000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	471114000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6922000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5524000	usd
CY2023Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	9018000	usd
CY2022Q1	us-gaap	Other Depreciation And Amortization OtherDepreciationAndAmortization	7942000	usd
CY2023Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	265000	usd
CY2022Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	216000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2547000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2122000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	11799000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	0	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	917000	usd
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	820000	usd
CY2023Q1	chct	Deferred Income Tax Expense Benefit Net Of Refunds DeferredIncomeTaxExpenseBenefitNetOfRefunds	35000	usd
CY2022Q1	chct	Deferred Income Tax Expense Benefit Net Of Refunds DeferredIncomeTaxExpenseBenefitNetOfRefunds	-17000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	2390000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	844000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	133000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	352000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-870000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-73000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12698000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14402000	usd
CY2023Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	23895000	usd
CY2022Q1	us-gaap	Payments To Acquire Commercial Real Estate PaymentsToAcquireCommercialRealEstate	5845000	usd
CY2023Q1	us-gaap	Payments To Acquire Other Receivables PaymentsToAcquireOtherReceivables	1295000	usd
CY2022Q1	us-gaap	Payments To Acquire Other Receivables PaymentsToAcquireOtherReceivables	1500000	usd
CY2023Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	750000	usd
CY2022Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	750000	usd
CY2023Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	4138000	usd
CY2022Q1	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1892000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-28578000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8487000	usd
CY2023Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	12000000	usd
CY2022Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	4000000	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	32000	usd
CY2022Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	40000	usd
CY2023Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	11646000	usd
CY2022Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	10969000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	8215000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
CY2023Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	100000	usd
CY2022Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	74000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8437000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7083000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7443000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1168000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12068000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2867000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4625000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1699000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	3866000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2476000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3274000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	982000	usd
CY2023Q1	chct	Reclassification Of Registration Statement Costs Incurred In Prior Year To Equity Issuance Costs ReclassificationOfRegistrationStatementCostsIncurredInPriorYearToEquityIssuanceCosts	52000	usd
CY2022Q1	chct	Reclassification Of Registration Statement Costs Incurred In Prior Year To Equity Issuance Costs ReclassificationOfRegistrationStatementCostsIncurredInPriorYearToEquityIssuanceCosts	119000	usd
CY2023Q1	chct	Increase Decrease In Fair Value Of Cash Flow Hedges IncreaseDecreaseInFairValueOfCashFlowHedges	-4973000	usd
CY2022Q1	chct	Increase Decrease In Fair Value Of Cash Flow Hedges IncreaseDecreaseInFairValueOfCashFlowHedges	11407000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	60000	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	12000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	192000	usd
CY2022Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	228000	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	732000	usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	974000000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	181	real_estate_property
CY2023Q1	chct	Number Of Real Estate Properties Accounted For As Financing Lease NumberOfRealEstatePropertiesAccountedForAsFinancingLease	1	real_estate_property
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	3000000	usd
CY2023Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	34	state
CY2023Q1	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	4000000	sqft
CY2023Q1	chct	Lessor Operating Lease Percentage Leased LessorOperatingLeasePercentageLeased	0.916
CY2023Q1	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P7Y4M24D
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates in the Condensed Consolidated Financial Statements</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may materially differ from those estimates.</span></div>
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3666000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1178000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	959000	usd
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	521000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4625000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1699000	usd
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	974000000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	181	real_estate_property
CY2023Q1	chct	Number Of Real Estate Properties Accounted For As Financing Lease NumberOfRealEstatePropertiesAccountedForAsFinancingLease	1	real_estate_property
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	3000000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	181	real_estate_property
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	974042000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	181	real_estate_property
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	974042000	usd
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	181	real_estate_property
CY2023Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	974042000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	67851000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	86063000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	79894000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	70085000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	64285000	usd
CY2023Q1	chct	Lessor Operating Lease Payments To Be Received After Four Year LessorOperatingLeasePaymentsToBeReceivedAfterFourYear	367034000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	735212000	usd
CY2023Q1	us-gaap	Straight Line Rent StraightLineRent	900000	usd
CY2022Q1	us-gaap	Straight Line Rent StraightLineRent	800000	usd
CY2023Q1	chct	Number Of Real Estate Properties Accounted For As Financing Lease NumberOfRealEstatePropertiesAccountedForAsFinancingLease	1	real_estate_property
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	3000000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Remainder Of Fiscal Year SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedRemainderOfFiscalYear	253000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Next Twelve Months SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedNextTwelveMonths	346000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Two Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedTwoYears	356000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Three Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedThreeYears	367000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received Four Years SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceivedFourYears	378000	usd
CY2023Q1	chct	Sales Type And Direct Financing Leases Lease Receivable To Be Received After Year Four SalesTypeAndDirectFinancingLeasesLeaseReceivableToBeReceivedAfterYearFour	5210000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Payments To Be Received SalesTypeAndDirectFinancingLeasesLeaseReceivablePaymentsToBeReceived	6910000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable Undiscounted Excess Amount SalesTypeAndDirectFinancingLeasesLeaseReceivableUndiscountedExcessAmount	3877000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	3033000	usd
CY2023Q1	us-gaap	Sales Type Lease Interest Income SalesTypeLeaseInterestIncome	100000	usd
CY2022Q1	us-gaap	Sales Type Lease Interest Income SalesTypeLeaseInterestIncome	100000	usd
CY2023Q1	chct	Lessee Number Of Operating Leases LesseeNumberOfOperatingLeases	4	lease
CY2023Q1	chct	Lessee Number Of Finance Leases LesseeNumberOfFinanceLeases	2	lease
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	32000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	106000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	43000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	154000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	44000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	154000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	44000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	154000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	45000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	154000	usd
CY2023Q1	chct	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	1148000	usd
CY2023Q1	chct	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	6956000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1356000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7678000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	573000	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	4400000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	783000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3278000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P36Y10D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P36Y8M23D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.040
CY2023Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P40Y6M21D
CY2022Q1	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P36Y9M
CY2023Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.042
CY2022Q1	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.041
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	16397000	usd
CY2023Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2023Q1	us-gaap	Derivative Assets DerivativeAssets	16397000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	365061000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	352997000	usd
CY2023Q1	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	-8500000	usd
CY2023Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	712000	usd
CY2023Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	15685000	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	712000	usd
CY2023Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	712000	usd
CY2023Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	712000	usd
CY2023Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2023Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	22667000	usd
CY2022Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	22667000	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	usd
CY2022Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	22667000	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	0	usd
CY2022Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	usd
CY2022Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral	0	usd
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25897000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24983000	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	249000	shares
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	600000	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	129000	shares
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	318000	shares
CY2023Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	1000	shares
CY2022	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	4000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	26274000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	25897000	shares
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-6922000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	5524000	usd
CY2023Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	822000	usd
CY2022Q1	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	658000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7744000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4866000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	26043000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	25060000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1816000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Restricted Stock WeightedAverageNumberOfSharesRestrictedStock	1490000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24227000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23570000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24227000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23570000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.21
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	11800000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	271000	usd
CY2023Q1	us-gaap	Notes Receivable Net NotesReceivableNet	33250000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	32705000	usd
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	5387000	usd
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2679000	usd
CY2023Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	16342000	usd
CY2022Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	15429000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1341000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	980000	usd
CY2023Q1	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	630000	usd
CY2022Q4	us-gaap	Other Deferred Costs Net OtherDeferredCostsNet	683000	usd
CY2023Q1	chct	Leasing Commissions Net LeasingCommissionsNet	2036000	usd
CY2022Q4	chct	Leasing Commissions Net LeasingCommissionsNet	1848000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	306000	usd
CY2023Q1	us-gaap	Interest Rate Fair Value Hedge Asset At Fair Value InterestRateFairValueHedgeAssetAtFairValue	16397000	usd
CY2022Q4	us-gaap	Interest Rate Fair Value Hedge Asset At Fair Value InterestRateFairValueHedgeAssetAtFairValue	22667000	usd
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	2441000	usd
CY2022Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	2399000	usd
CY2023Q1	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	3033000	usd
CY2022Q4	us-gaap	Sales Type And Direct Financing Leases Lease Receivable SalesTypeAndDirectFinancingLeasesLeaseReceivable	3035000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2530000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2545000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	751000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	759000	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	580000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	496000	usd
CY2023Q1	us-gaap	Other Assets OtherAssets	84989000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	86531000	usd
CY2023Q1	chct	Other Liabilities Miscellaneous OtherLiabilitiesMiscellaneous	846000	usd
CY2023Q1	us-gaap	Advance Rent AdvanceRent	4862000	usd
CY2022Q4	us-gaap	Advance Rent AdvanceRent	3853000	usd
CY2023Q1	us-gaap	Security Deposit Liability SecurityDepositLiability	3615000	usd
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	5766000	usd
CY2023Q1	us-gaap	Below Market Lease Net BelowMarketLeaseNet	2144000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	1075000	usd
CY2023Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	712000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	3278000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	3279000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	783000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	786000	usd
CY2022Q4	chct	Other Liabilities Miscellaneous OtherLiabilitiesMiscellaneous	478000	usd
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	16240000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	15237000	usd

Files In Submission

Name	View Source	Status
chct-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
0001631569-23-000040-index-headers.html	Edgar Link	pending
0001631569-23-000040-index.html	Edgar Link	pending
0001631569-23-000040.txt	Edgar Link	pending
0001631569-23-000040-xbrl.zip	Edgar Link	pending
chct-20230331.htm	Edgar Link	pending
chct-20230331.xsd	Edgar Link	pending
chct-20230331xexhibitx311.htm	Edgar Link	pending
chct-20230331xexhibitx321.htm	Edgar Link	pending
chct-20230331_cal.xml	Edgar Link	unprocessable
chct-20230331_def.xml	Edgar Link	unprocessable
chct-20230331_htm.xml	Edgar Link	completed
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
chct-20230331_lab.xml	Edgar Link	unprocessable
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CHCT
Community Healthcare Trust Inc Stock $chct

2023 Q2 Form 10-Q Financial Statement

#000163156923000040 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCT Community Healthcare Trust Inc Stock $chct

2023 Q2 Form 10-Q Financial Statement

#000163156923000040 Filed on May 02, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CHCT
Community Healthcare Trust Inc Stock $chct